FindTrial
Sign In

"Clinical relevance of immature platelet fraction in thrombocytopenia and its role in differentiating bone marrow suppression and destruction of platelets"

Clinical relevance of immature platelet fraction in thrombocytopenia and its role in differentiating bone marrow suppression and destruction of platelets - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2024/02/063089
Enrollment
300
Registered
2024-02-23
Start date
Unknown
Completion date
Unknown
Last updated
2024-03-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D61- Other aplastic anemias and other bone marrow failure syndromes Health Condition 2: D69- Purpura and other hemorrhagic conditions

Interventions

Intervention1: NIL: NIL

Sponsors

Kasturba Medical College MAHE Manipal RESEARCH GRANT
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All adults (18years and above) having thrombocytopenia with a definitive diagnosis

Exclusion criteria

Exclusion criteria: 1) All pediatric patients 2) Samples with platelet clumps 3) Patients on drug therapy / chemotherapy

Design outcomes

Primary

MeasureTime frame
• To determine immature platelet fraction in patients with thrombocytopenia using automated hematology analyzer (SYSMEX XN-1500) • To determine normal reference range of immature platelet fraction in healthy controlsTimepoint: 11 months (1 march 2023 to 28 february 2024)—

Secondary

MeasureTime frame
To determine whether immature platelet fraction can be used reliably to distinguish between hypo-productive thrombocytopenia and hyper-destructive thrombocytopeniaTimepoint: 11 months (1 march 2023 to 28 february 2024)—

Countries

India

Contacts

Public ContactDR SOUMYA MITRUKA

Kasturba Medical College MAHE Manipal

sushma.b@manipal.edu8287920677

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026